Popular Articles

Antisense Therapeutics Drug ATL1101 Enhances Effect Of Existing Chemotherapy Treatment On Prostate Tumors
Antisense Therapeutics Ltd. (ASX: ANP) is pleased to report further positive results from its collaborative preclinical research studies on the therapeutic potential of ATL1101 in prostate cancer. In experimental models, ATL1101 treatment significantly enhanced the tumor-suppressive effect of the cancer drug Paclitaxel. Paclitaxel is one of a class of drugs known as taxanes. Along with androgen (a male hormone) blockade, taxane chemotherapy is an important treatment option in the most dangerous form of the disease, castration-resistant prostate cancer (CRPC).
generic viagra online
FDA Approves Feraheme™ To Treat Iron Deficiency Anemia In Adult Chronic Kidney Disease Patients
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Feraheme™ (ferumoxytol) Injection for intravenous (IV) use as an iron replacement therapy for the treatment of iron deficiency anemia in adult patients with chronic kidney disease. The recommended dose of Feraheme is an initial 510 mg IV injection followed by a second 510 mg IV injection three to eight days later. Feraheme should be administered as an undiluted IV injection delivered at a rate of up to 1 mL/sec (30 mg/sec). The recommended Feraheme dose may be readministered to patients with persistent or recurrent iron deficiency anemia.
News of the day
Fatal Injuries To Workers In Britain At Record Low, UK
The number of people killed at work in Britain has fallen to a record low, new figures from the Health and Safety Executive (HSE) reveal.
Cardiovascular

Physicians To Make Denton House Call On Health System Reform

What The Texas Medical Association (TMA) along with Denton County Medical Society (DCMS) physician leaders are hosting a town hall meeting - "a House Call" - this week. Physicians are inviting patients, business leaders, and national and state elected officials to attend the local community House Call on health system reform. Physicians want to learn firsthand how patients feel about the current health system reform proposals. Should there be a "public option?" Should government overhaul Medicare or Medicaid? These and many more questions are on the table, and the answers affect every single Texan - insured or uninsured, wealthy or poor. When Wednesday, July 29, 2009, 6:30-8:30 pm Where Denton County Courthouse-on-the-Square, 110 W. Hickory St., Denton Who Susan Rudd Bailey, MD, TMA president-elect; John G. Flores, MD, DCMS vice president/programs chair; other local physician leaders; members of Congress or key staff; members of the Texas Legislature or key staff; and local business leaders Why TMA strongly believes that Texas and America needs true health system reform. However, any reform must put the patient first. It also must preserve the time-honored patient-physician relationship. This is the first of several House Calls TMA and local physicians are hosting across Texas to learn patients" opinions about the current debate on national health care reform so TMA can better advocate on their behalf in Washington, D.C. Doctors want patients to share one thing they like most about today"s health care system, one thing they would change about the current health care system, and what patients want and do not want from health system reform. If patients cannot attend the meeting, they can still join the debate online by visiting http://www.MeandMyDoctor.com. People can answer the same questions online and join the grassroots action campaign. Patients also may view the House Call live online via video stream. TMA is the largest state medical society in the nation, representing nearly 44,000 physician and medical student members. It is located in Austin and has 120 component county medical societies around the state. TMA"s key objective since 1853 is to improve the health of all Texans. Texas Medical Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):